This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Gallardo E, Medina J, Sánchez JC, Viudez A, Grande E, Porras I, et al. SEOM clinical guideline thyroid cancer (2019). Clin. Transl. Oncol. 2020;22(2):223–235. https://doi.org/10.1007/s12094-019-02284-8GallardoEMedinaJSánchezJCViudezAGrandeEPorrasISEOM clinical guideline thyroid cancer (2019)2020222223235https://doi.org/10.1007/s12094-019-02284-8Search in Google Scholar
Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2022. CA. Cancer. J. Clin. 2022;72(1):7–33. https://doi.org/10.3322/caac.21708SiegelRLMillerKDFuchsHEJemalA.Cancer statistics, 20222022721733https://doi.org/10.3322/caac.21708Search in Google Scholar
El-Gammal Hammed ER, El-Azonny MM, Al-Shamy AT. ROLE OF LEVEL V LYMPH NODE DISSECTION IN N1b PAPILLARY THYROID CARCINOMA. Al-Azhar. Med. J. 2019;48(4):421–434. https://doi:10.21608/amj.2019.64949El-Gammal HammedEREl-AzonnyMMAl-ShamyATROLE OF LEVEL V LYMPH NODE DISSECTION IN N1b PAPILLARY THYROID CARCINOMA2019484421434https://doi:10.21608/amj.2019.64949Search in Google Scholar
Dal Maso L, Tavilla A, Pacini F, Serraino D, van Dijk BAC, Chirlaque MD, et al. Survival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5. Eur. J. Cancer. 2017;77:140–152. https://doi.org/10.1016/j.ejca.2017.02.023Dal MasoLTavillaAPaciniFSerrainoDvan DijkBACChirlaqueMDSurvival of 86,690 patients with thyroid cancer: a population-based study in 29 European countries from EUROCARE-5201777140152https://doi.org/10.1016/j.ejca.2017.02.023Search in Google Scholar
Sanabria A, Kowalski LP, Shah JP, Nixon IJ, Angelos P, Williams MD, et al. Growing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis. Head. Neck. 2018;40(4):855–866. https://doi.org/10.1002/hed.25029SanabriaAKowalskiLPShahJPNixonIJAngelosPWilliamsMDGrowing incidence of thyroid carcinoma in recent years: Factors underlying overdiagnosis2018404855866https://doi.org/10.1002/hed.25029Search in Google Scholar
Katoh H, Yamashita K, Enomoto T, Watanabe M. Classification and general considerations of thyroid cancer. Ann. Clin. Pathol. 2015;3(1):1045.KatohHYamashitaKEnomotoTWatanabeMClassification and general considerations of thyroid cancer2015311045Search in Google Scholar
Giordano TJ. Genomic Hallmarks of Thyroid Neoplasia. Annu. Rev. Pathol.: Mechanisms of Disease. 2018;13(1):141–162. https://doi.org/10.1146/annurev-pathol-121808-102139GiordanoTJGenomic Hallmarks of Thyroid Neoplasia2018131141162https://doi.org/10.1146/annurev-pathol-121808-102139Search in Google Scholar
Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse klotho gene leads to a syndrome resembling ageing. Nature. 1997;390(1):45–51. https://doi.org/10.1038/36285Kuro-oMMatsumuraYAizawaHKawaguchiHSugaTUtsugiTMutation of the mouse klotho gene leads to a syndrome resembling ageing199739014551https://doi.org/10.1038/36285Search in Google Scholar
Wang Y, Sun Z. Current understanding of klotho. Ageing. Res. Rev. 2009;8(1):43–51. https://doi.org/10.1016/j.arr.2008.10.002WangYSunZCurrent understanding of klotho2009814351https://doi.org/10.1016/j.arr.2008.10.002Search in Google Scholar
Ito S, Fujimori T, Hayashizaki Y, Nabeshima Y. Identification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure. Biochim. Biophys. Acta. 2002;1576(3):341–345. https://doi.org/10.1016/s0167-4781(02)00281-6ItoSFujimoriTHayashizakiYNabeshimaYIdentification of a novel mouse membrane-bound family 1 glycosidase-like protein, which carries an atypical active site structure200215763341345https://doi.org/10.1016/s0167-4781(02)00281-6Search in Google Scholar
Hori S, Miyake M, Tatsumi Y, Morizawa Y, Nakai Y, Onishi S, et al. Gamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer. Oncotarget. 2018;9(28):19508–19524. https://doi.org/10.18632/oncotarget.24628HoriSMiyakeMTatsumiYMorizawaYNakaiYOnishiSGamma-Klotho exhibits multiple roles in tumor growth of human bladder cancer20189281950819524https://doi.org/10.18632/oncotarget.24628Search in Google Scholar
Kurosu H, Kuro-o M. The Klotho gene family as a regulator of endocrine fibroblast growth factors. Mol. Cell. Endocrinol. 2009;299(1):72–78. https://doi.org/10.1016/j.mce.2008.10.052KurosuHKuro-oMThe Klotho gene family as a regulator of endocrine fibroblast growth factors200929917278https://doi.org/10.1016/j.mce.2008.10.052Search in Google Scholar
Xie B, Chen J, Liu B, Zhan J. Klotho Acts as a Tumor Suppressor in Cancers. Pathol. Oncol. Res. 2013;19(4):611–617. https://doi.org/10.1007/s12253-013-9663-8XieBChenJLiuBZhanJKlotho Acts as a Tumor Suppressor in Cancers2013194611617https://doi.org/10.1007/s12253-013-9663-8Search in Google Scholar
Peshes-Yeloz N, Ungar L, Wohl A, Jacoby E, Fisher T, Leitner M, et al. Role of Klotho protein in tumorigenesis, cancer progression, and prognosis in patients with high-grade glioma. World. Neurosurg. 2019;130:e324–e332. https://doi.org/10.1016/j.wneu.2019.06.082Peshes-YelozNUngarLWohlAJacobyEFisherTLeitnerMRole of Klotho protein in tumorigenesis, cancer progression, and prognosis in patients with high-grade glioma2019130e324e332https://doi.org/10.1016/j.wneu.2019.06.082Search in Google Scholar
Chen B, Liang Y, Chen L, Wei Y, Li Y, Zhao W, et al. Overexpression of Klotho Inhibits HELF Fibroblasts SASP-related Protumoral Effects on Non-small Cell Lung Cancer Cells. J. Cancer. 2018;9(7):1248–1258. https://doi.org/10.7150/jca.23967ChenBLiangYChenLWeiYLiYZhaoWOverexpression of Klotho Inhibits HELF Fibroblasts SASP-related Protumoral Effects on Non-small Cell Lung Cancer Cells20189712481258https://doi.org/10.7150/jca.23967Search in Google Scholar
Trošt N, Peña-Llopis S, Koirala S, Stojan J, Potts PR, Tacer KF, et al. γKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers. Oncotarget. 2016;7(3):2611–2628. https://doi.org/10.18632/oncotarget.6006TroštNPeña-LlopisSKoiralaSStojanJPottsPRTacerKFγKlotho is a novel marker and cell survival factor in a subset of triple negative breast cancers20167326112628https://doi.org/10.18632/oncotarget.6006Search in Google Scholar
Anderson CE, Mclaren KM. Best Practice No 171: Best practice in thyroid pathology. J. Clin. Pathol. 2003;56(6):401–405. http://dx.doi.org/10.1136/jcp.56.6.401AndersonCEMclarenKMBest Practice No 171: Best practice in thyroid pathology2003566401405http://dx.doi.org/10.1136/jcp.56.6.401Search in Google Scholar
Chomczynski P, Sacchi N. The single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on. Nat. protoc. 2006;1(2):581–585. https://doi.org/10.1038/nprot.2006.83ChomczynskiPSacchiNThe single-step method of RNA isolation by acid guanidinium thiocyanate–phenol–chloroform extraction: twenty-something years on200612581585https://doi.org/10.1038/nprot.2006.83Search in Google Scholar
Freeman WM, Walker SJ, Vrana KE. Quantitative RT-PCR: pitfalls and potential. Biotechniques. 1999;26(1):112–125. https://doi.org/10.2144/99261rv01FreemanWMWalkerSJVranaKEQuantitative RT-PCR: pitfalls and potential1999261112125https://doi.org/10.2144/99261rv01Search in Google Scholar
Zhang M, Zhao J, Tang W, Wang Y, Peng P, Li L, et al. High Hepsin expression predicts poor prognosis in Gastric Cancer. Sci. Rep. 2016;6(1):1–10. https://doi.org/10.1038/srep36902ZhangMZhaoJTangWWangYPengPLiLHigh Hepsin expression predicts poor prognosis in Gastric Cancer201661110https://doi.org/10.1038/srep36902Search in Google Scholar
Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method. Methods. 2001;25(4):402–408. https://doi.org/10.1006/meth.2001.1262LivakKJSchmittgenTDAnalysis of relative gene expression data using real-time quantitative PCR and the 2−ΔΔCT method2001254402408https://doi.org/10.1006/meth.2001.1262Search in Google Scholar
Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993;39(4):561–577. https://doi.org/10.1093/clinchem/39.4.561ZweigMHCampbellGReceiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine1993394561577https://doi.org/10.1093/clinchem/39.4.561Search in Google Scholar
Wolf I, Levanon-Cohen S, Bose S, Ligumsky H, Sredni B, Kanety H, et al. Klotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer. Oncogene. 2008;27(56):7094–7105. https://doi.org/10.1038/onc.2008.292WolfILevanon-CohenSBoseSLigumskyHSredniBKanetyHKlotho: a tumor suppressor and a modulator of the IGF-1 and FGF pathways in human breast cancer2008275670947105https://doi.org/10.1038/onc.2008.292Search in Google Scholar
Rubinek T, Wolf I. The Role of Alpha-Klotho as a Universal Tumor Suppressor. Vitam. Horm. 2016;101:197–214. https://doi.org/10.1016/bs.vh.2016.03.001RubinekTWolfIThe Role of Alpha-Klotho as a Universal Tumor Suppressor2016101197214https://doi.org/10.1016/bs.vh.2016.03.001Search in Google Scholar
Arbel Rubinstein T, Reuveni I, Hesin A, Klein-Goldberg A, Olauson H, Larsson TE, et al. A Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy. Cancers (Basel). 2021;13(24):6297. https://doi.org/10.3390/cancers13246297Arbel RubinsteinTReuveniIHesinAKlein-GoldbergAOlausonHLarssonTEA Transgenic Model Reveals the Role of Klotho in Pancreatic Cancer Development and Paves the Way for New Klotho-Based Therapy202113246297https://doi.org/10.3390/cancers13246297Search in Google Scholar
Huang S, Wang W, Cheng Y, Lin J, Wang M. Clinicopathological and prognostic significance of klotho and estrogen receptors expression in human hepatocellular carcinoma. Turk. J. Gastroenterol. 2021;32(10):828–836. https://doi.org/10.5152/tjg.2021.19986HuangSWangWChengYLinJWangMClinicopathological and prognostic significance of klotho and estrogen receptors expression in human hepatocellular carcinoma20213210828836https://doi.org/10.5152/tjg.2021.19986Search in Google Scholar
Lu L, Katsaros D, Wiley A, Rigault de la Longrais IA, Puopolo M, Yu H. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Cancer. Invest. 2008;26(2):185–192. https://doi.org/10.1080/07357900701638343LuLKatsarosDWileyARigault de la LongraisIAPuopoloMYuHKlotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression2008262185192https://doi.org/10.1080/07357900701638343Search in Google Scholar
Pawlikowski M, Pisarek H, Borkowska M, Winczyk K. Expression of α-Klotho protein in human thyroid cancers—an immunohistochemical study. Endokrynol. Pol. 2019;70(3):237–240. https://doi.org/10.5603/EP.a2019.0004PawlikowskiMPisarekHBorkowskaMWinczykKExpression of α-Klotho protein in human thyroid cancers—an immunohistochemical study2019703237240https://doi.org/10.5603/EP.a2019.0004Search in Google Scholar
Dai D, Wang Q, Li X, Liu J, Ma X, Xu W. Klotho inhibits human follicular thyroid cancer cell growth and promotes apoptosis through regulation of the expression of stanniocalcin-1. Oncol. Rep. 2016;35(1):552–558. https://doi.org/10.3892/or.2015.4358DaiDWangQLiXLiuJMaXXuWKlotho inhibits human follicular thyroid cancer cell growth and promotes apoptosis through regulation of the expression of stanniocalcin-12016351552558https://doi.org/10.3892/or.2015.4358Search in Google Scholar
Wu Q, Jiang L, Wu J, Dong H, Zhao Y. Klotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway. Cancer. Manag. Res. 2021;13:4791–4802. https://doi.org/10.2147/CMAR.S295086WuQJiangLWuJDongHZhaoYKlotho Inhibits Proliferation in a RET Fusion Model of Papillary Thyroid Cancer by Regulating the Wnt/β-Catenin Pathway20211347914802https://doi.org/10.2147/CMAR.S295086Search in Google Scholar
Saran S. Multinodular goiter. In: Agrawal NK, editor. Goiter-Causes and Treatment. London: IntechOpen; 2020. p. 99–110. http://dx.doi.org/10.5772/intechopen.90325SaranSMultinodular goiterIn:AgrawalNKeditor.LondonIntechOpen202099110http://dx.doi.org/10.5772/intechopen.90325Search in Google Scholar
Hammad MO, Elabbasy LM, Abd Elghaffar MA, Zaki MM, Bazeed FB, Zahran MA. Significance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis. Asia. Pac. J. Clin. Oncol. 2019;15(5):e154–e161. https://doi.org/10.1111/ajco.13143HammadMOElabbasyLMAbd ElghaffarMAZakiMMBazeedFBZahranMASignificance of CEP78 and WDR62 gene expressions in differentiated thyroid carcinoma: Possible predictors of lateral lymph node metastasis2019155e154e161https://doi.org/10.1111/ajco.13143Search in Google Scholar
Xu X, Hao Y, Zhong Q, Hang J, Zhao Y, Qiao J. Low KLOTHO level related to aging is associated with diminished ovarian reserve. Fertil. Steril. 2020;114(6):1250–1255. https://doi.org/10.1016/j.fertnstert.2020.06.035XuXHaoYZhongQHangJZhaoYQiaoJLow KLOTHO level related to aging is associated with diminished ovarian reserve2020114612501255https://doi.org/10.1016/j.fertnstert.2020.06.035Search in Google Scholar
Lee HJ, Choi JY, Lee J, Kim D, Min JY, Min KB. Association between serum uric acid and α-klotho protein levels in the middle-aged population. Aging (Albany NY). 2022;14(6):2537–2547. https://doi.org/10.18632/aging.203987LeeHJChoiJYLeeJKimDMinJYMinKBAssociation between serum uric acid and α-klotho protein levels in the middle-aged population202214625372547https://doi.org/10.18632/aging.203987Search in Google Scholar
Li Y, Xiao HJ, Xue F. Overexpression of klotho suppresses growth and pulmonary metastasis of osteosarcoma in vivo. Genet. Mol. Biol. 2020;43(2):e20190229. https://doi.org/10.1590/1678-4685-GMB-2019-0229LiYXiaoHJXueFOverexpression of klotho suppresses growth and pulmonary metastasis of osteosarcoma in vivo2020432e20190229https://doi.org/10.1590/1678-4685-GMB-2019-0229Search in Google Scholar
Zhou X, Fang X, Jiang Y, Geng L, Li X, Li Y, et al. Klotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma. J. Hematol. Oncol. 2017;10(1):1–1. https://doi.org/10.1186/s13045-017-0391-5ZhouXFangXJiangYGengLLiXLiYKlotho, an anti-aging gene, acts as a tumor suppressor and inhibitor of IGF-1R signaling in diffuse large B cell lymphoma201710111https://doi.org/10.1186/s13045-017-0391-5Search in Google Scholar
Onishi K, Miyake M, Hori S, Onishi S, Lida K, Morizawa Y, et al. γ-Klotho is correlated with resistance to docetaxel in castration-resistant prostate cancer. Oncol. Lett. 2020;19(3):2306–2316. https://doi.org/10.3892/ol.2020.11308OnishiKMiyakeMHoriSOnishiSLidaKMorizawaYγ-Klotho is correlated with resistance to docetaxel in castration-resistant prostate cancer202019323062316https://doi.org/10.3892/ol.2020.11308Search in Google Scholar
Su J, Ma Q, Long W, Tang H, Wu C, Luo M, et al. LCTL is a prognostic biomarker and correlates with stromal and immune infiltration in gliomas. Front. Oncol. 2019;9:1083 https://doi.org/10.3389/fonc.2019.01083SuJMaQLongWTangHWuCLuoMLCTL is a prognostic biomarker and correlates with stromal and immune infiltration in gliomas20199108https://doi.org/10.3389/fonc.2019.01083Search in Google Scholar